If you are asking whether arthrosamid injections are worth it, you are really asking whether the likely pain relief and improved movement are enough to justify the treatment. That matters because Arthrosamid is aimed at symptomatic knee osteoarthritis, not every type of arthritis or every painful joint.

What arthrosamid injections are

At a basic level, arthrosamid injections involve a single injection of a non-absorbable, biocompatible hydrogel into the knee joint. The official patient information says the product is intended for the symptomatic treatment of adult patients with knee osteoarthritis, and published clinical papers describe the material as 97.5% water and 2.5% cross-linked polyacrylamide.

That matters because it is not being presented as a cure or a way to rebuild worn cartilage from scratch. They are positioned as a non-surgical option to help reduce symptoms and improve function, which is a more realistic and useful way to judge whether they are worth considering.

Why some people think they are worth it

The main argument in favour of injections for arthrosamid is durability. A 2024 study reported sustained benefits and safety through 52 weeks after a single injection, while a longer-term follow-up published in 2025 reported that the hydrogel remained safe and may be effective five years after one injection. That is a meaningful selling point for people who want something longer-lasting than a short-term flare fix.

For the right patient, arthrosamid injections may look especially appealing because they offer a one-step outpatient treatment rather than repeated procedures. That can sound attractive if knee osteoarthritis is limiting walking, stairs, exercise, or day-to-day comfort and the patient wants a non-surgical option before moving further down the treatment pathway.

Still, arthrosamid injections are not an automatic yes. One randomised trial found the treatment to be as effective and safe as hyaluronic acid over at least one year, which is encouraging, but “as effective as” is not the same thing as clearly superior. For some people, that may still be enough; for others, it makes the answer less straightforward.

Where the caution comes in

The biggest caution around arthrosamid comes from the current evidence position. NICE states that Arthrosamid was not selected for Health Technology Evaluation guidance because the panel considered there to be insufficient evidence. That does not prove the treatment does not work, but it does show that the evidence base is not yet strong enough for NICE to take it forward in that process.

That means arthrosamid injections sit in an interesting middle ground. There are promising clinical findings, including longer-term follow-up data, but there is still a difference between encouraging results and a firmly established place in mainstream guidance. In plain English, the treatment may be promising, but it is not fully settled territory yet.

So, are arthrosamid injections worth it if you want certainty? Probably not, because certainty is not what current research offers. Are they worth considering if you have symptomatic knee osteoarthritis, want a non-surgical option, and understand that the evidence is promising rather than definitive? That is a more reasonable yes.

Who may find them worthwhile

In practice, arthrosamid injections make more sense for people with a clear diagnosis of knee osteoarthritis who want to improve pain and function without jumping straight to surgery. They make less sense if the diagnosis is unclear, if the painful joint is not the knee, or if core management such as exercise, weight management, and broader osteoarthritis care has not been properly addressed first.

The best way to judge injections for arthrosamid is not to ask only whether they sound advanced. Ask whether your diagnosis is correct, whether the expected benefits match your goals, and whether you are comfortable with a treatment that has positive study results but still sits under an “insufficient evidence” cloud from NICE. That is usually a smarter decision-making process than chasing the newest option because it sounds impressive.

Final thoughts

In the end, arthrosamid injections may be worth it for some patients with knee osteoarthritis, especially those looking for a non-surgical option with the potential for longer-lasting symptom relief from a single injection. The key is to approach the treatment with realistic expectations, a proper assessment, and a clear understanding of both the promise and the limits of the evidence. Read more from Regenesis or speak to a clinician to explore whether Arthrosamid is a sensible fit for your situation.